The use of aripiprazole in early onset schizophrenia: safety and efficacy
The use of atypical antipsychotic agents in early onset schizophrenia is rising despite its limited data on efficacy, safety and tolerability. Early onset schizophrenia warrants effective pharmacological treatment that is safe and well tolerated by children and adolescent population. Existing atypic...
Main Authors: | Ibrahim, Normala, Awang, Hamidin |
---|---|
Format: | Article |
Language: | English English |
Published: |
Malaysian Medical Association
2009
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/17356/1/The%20use%20of%20aripiprazole%20in%20early%20onset%20schizophrenia.pdf |
Similar Items
-
Aripiprazole for refractory catatonic schizophrenia – A case report
by: Saisudha N V Gorthi, et al.
Published: (2015-01-01) -
Schizophrenia: effects of aripiprazole in metabolic syndrome
by: Deborah Galvão Coelho da Silva, et al.
Published: (2019-11-01) -
Cognitive-behavioral therapy of schizophrenia /
by: 433920 Kingdon, David G., et al.
Published: (1994) -
Aripiprazole LAI two‐injection start in a 16 year‐old adolescent with schizophrenia
by: Virginio Salvi, et al.
Published: (2022-06-01) -
Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review
by: Kunal Maini, et al.
Published: (2021-07-01)